CIK 0000842023
- Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- Operating
- EIN
- 411427402
- Phone
- +1 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-08-07 | Gavin Robert M. Senior V.P. Protein Platforms | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2015-08-07 | Gavin Robert M. Senior V.P. Protein Platforms | Grant or award · Stock Option (Right to Buy) | +6,250 | 6,250 | ||
| 2015-08-07 | Gavin Robert M. Senior V.P. Protein Platforms | Grant or award · Restricted Stock Units | +1,000 | 1,000 | ||
| 2015-08-07 | Bazan J. Fernando Chief Technical Officer | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2015-08-07 | Bazan J. Fernando Chief Technical Officer | Grant or award · Stock Options (Right to Buy) | +5,000 | 5,000 | ||
| 2015-08-07 | Bazan J. Fernando Chief Technical Officer | Grant or award · Restricted Stock Units | +800 | 800 | ||
| 2015-08-07 | Hippel James Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2015-08-07 | Hippel James Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2015-08-07 | Hippel James Chief Financial Officer | Grant or award · Restricted Stock Unit | +2,000 | 2,000 | ||
| 2015-08-07 | Furlow Brenda S. SVP - General Counsel | Shares withheld for taxes | −277 | $97.54 | $27K | 2,223 |
| 2015-08-07 | Furlow Brenda S. SVP - General Counsel | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2015-08-07 | Furlow Brenda S. SVP - General Counsel | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2015-08-07 | Furlow Brenda S. SVP - General Counsel | Grant or award · Restricted Stock Units | +800 | 800 | ||
| 2015-08-07 | VERONNEAU MARCEL SVP - Clinical Controls | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2015-08-07 | VERONNEAU MARCEL SVP - Clinical Controls | Grant or award · Stock Option (Right to Buy) | +3,750 | 3,750 | ||
| 2015-08-07 | VERONNEAU MARCEL SVP - Clinical Controls | Grant or award · Restricted Stock Units | +600 | 600 | ||
| 2015-08-07 | Eansor Norman David SVP - Novus Biologicals | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2015-08-07 | Eansor Norman David SVP - Novus Biologicals | Grant or award · Stock Option (Right to Buy) | +6,250 | 6,250 | ||
| 2015-08-07 | Eansor Norman David SVP - Novus Biologicals | Grant or award · Restricted Stock Units | +1,000 | 1,000 | ||
| 2015-08-07 | Kummeth Charles R. Chief Executive Officer | Grant or award | +11,522 | 44,377 |
Page 66 of 75 · 1,487 trades